CVS 2018 Formulary: Outcomes-Based Contracts In Oncology, Obesity, COPD

And for diabetes, Jardiance is out and Invokana is in; CVS formulary update includes far fewer exclusions than previous years and reinstates coverage for several drugs, signaling more muted approach to management.

shelves

More from Pricing Debate

More from Market Access